{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:02:33Z","timestamp":1785416553098,"version":"3.56.0"},"reference-count":95,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["2025CXGC010615"],"award-info":[{"award-number":["2025CXGC010615"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Fund Project of Shandong University of Traditional Chinese Medicine","award":["KYZK2024Z06"],"award-info":[{"award-number":["KYZK2024Z06"]}]},{"name":"Scientific Research Fund Project of Shandong University of Traditional Chinese Medicine","award":["LCKY202515"],"award-info":[{"award-number":["LCKY202515"]}]},{"name":"Scientific Research Fund Project of Shandong University of Traditional Chinese Medicine","award":["LCKY202510"],"award-info":[{"award-number":["LCKY202510"]}]},{"name":"Key Teaching Reform Project of Undergraduate Colleges and Universities in Shandong Province","award":["Z2022158"],"award-info":[{"award-number":["Z2022158"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine\u2013metabolic disorder characterized by dysregulated ovarian signaling, metabolic inflammation, insulin resistance, and aberrant angiogenesis, for which effective disease-modifying therapies remain limited. Resveratrol (RES), a pleiotropic polyphenol, has attracted increasing attention for its ability to modulate multiple molecular and cellular pathways implicated in PCOS pathophysiology. In this review, we synthesize current evidence to clarify how RES regulates key pathological signaling networks in PCOS, including ovarian follicular dysfunction, impaired insulin signaling, hyperandrogenism, oxidative stress, and vascular remodeling. Rather than merely cataloguing isolated mechanisms, we integrate findings from experimental models to highlight major convergent nodes\u2014such as phosphoinositide 3-kinase (PI3K)\/protein kinase B (Akt)\/mechanistic target of rapamycin (mTOR), sirtuin 1 (SIRT1)\/AMP-activated protein kinase (AMPK), nuclear factor kappa-B (NF-\u03baB), and vascular endothelial growth factor (VEGF)-related pathways\u2014through which RES may exert coordinated regulatory effects at the cellular and tissue levels. We further examine the available clinical studies to assess the translational relevance of these mechanistic insights, with particular emphasis on phenotypic heterogeneity, dose dependence, and the treatment window. Although clinical outcomes remain modest and variable, the available evidence suggests that RES may provide context-dependent benefits in selected PCOS subtypes. Collectively, this review offers a network-based framework linking the molecular actions of RES to the complex pathophysiology of PCOS and identifies key knowledge gaps that must be addressed to improve translational precision and therapeutic applicability.<\/jats:p>","DOI":"10.31083\/fbl50398","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:17:49Z","timestamp":1785413869000},"source":"Crossref","is-referenced-by-count":0,"title":["Resveratrol-Mediated Regulation of Molecular and Cellular Signaling Networks in Polycystic Ovary Syndrome"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-8748","authenticated-orcid":true,"given":"Ruirui","family":"Hou","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ren","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Meng","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. The Lancet. Diabetes & Endocrinology. 2022; 10: 668\u2013680.","DOI":"10.1016\/S2213-8587(22)00163-2"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Motlagh Asghari K, Nejadghaderi SA, Alizadeh M, Sanaie S, Sullman MJM, Kolahi AA, et al. Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990-2019. Scientific Reports. 2022; 12: 7039.","DOI":"10.1038\/s41598-022-11006-0"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 2024; 310: 1303\u20131314.","DOI":"10.1007\/s00404-024-07607-x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Huang J, Tian Y, Liu X, Xu Z, Li C, Zhu L. Trimethylamine N-oxide Supplementation Enhances the Quality of Oocytes in Mice of Polycystic Ovary Syndrome. Frontiers in Bioscience (Landmark Edition). 2025; 30: 38078.","DOI":"10.31083\/fbl38078"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Teede HJ, Gibson M, Laven J, Dokras A, Moran LJ, Piltonin T, et al. International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women's health condition. EClinicalMedicine. 2024; 78: 102927.","DOI":"10.1016\/j.eclinm.2024.102927"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Farhan M, Rizvi A. The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development. Nutrients. 2023; 15: 4486.","DOI":"10.3390\/nu15204486"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Britton RG, Kovoor C, Brown K. Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Annals of the New York Academy of Sciences. 2015; 1348: 124\u2013133.","DOI":"10.1111\/nyas.12796"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Podgrajsek R, Ban Frangez H, Stimpfel M. Molecular Mechanism of Resveratrol and Its Therapeutic Potential on Female Infertility. International Journal of Molecular Sciences. 2024; 25: 3613.","DOI":"10.3390\/ijms25073613"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Chang H, Shi B, Wang Y, Lu F, Guan M, Wu X. Effect and mechanism of resveratrol against polycystic ovary syndrome: a review. Frontiers in Endocrinology. 2025; 16: 1529231.","DOI":"10.3389\/fendo.2025.1529231"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update. 2003; 9: 505\u2013514.","DOI":"10.1093\/humupd\/dmg044"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Kong XX, Fu YC, Xu JJ, Zhuang XL, Chen ZG, Luo LL. Resveratrol, an effective regulator of ovarian development and oocyte apoptosis. Journal of Endocrinological Investigation. 2011; 34: e374\u201381.","DOI":"10.3275\/7853"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Liu M, Yin Y, Ye X, Zeng M, Zhao Q, Keefe DL, et al. Resveratrol protects against age-associated infertility in mice. Human Reproduction (Oxford, England). 2013; 28: 707\u2013717.","DOI":"10.1093\/humrep\/des437"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Furat Rencber S, Kurnaz Ozbek S, Eraldem\u0131r C, Sezer Z, Kum T, Ceylan S, et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. Journal of Ovarian Research. 2018; 11: 55.","DOI":"10.1186\/s13048-018-0427-7"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Yarmolinskaya M, Bulgakova O, Abashova E, Borodina V, Tral T. The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 2021; 37: 54\u201357.","DOI":"10.1080\/09513590.2021.2014665"},{"key":"ref15","unstructured":"Hu J, Ma Z, Zhang H, Wang L. Effects of resveratrol on mitochondrial function and apoptosis inhibition in ovarian granulosa cells of rats with polycystic ovary syndrome. Journal of Chongqing Medical University. 2024; 49: 264\u2013269. (In Chinese)"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Bahramrezaie M, Amidi F, Aleyasin A, Saremi A, Aghahoseini M, Brenjian S, et al. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. Journal of Assisted Reproduction and Genetics. 2019; 36: 1701\u20131712.","DOI":"10.1007\/s10815-019-01461-6"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Ajabi Ardehjani N, Agha-Hosseini M, Shabani Nashtaei M, Khodarahmian M, Seyyed Ebrahimi SS, Bagheri MH, et al. Beneficial Role of Resveratrol on Oxidative Stress in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial. Reproductive Sciences (Thousand Oaks, Calif.). 2025; 32: 3371\u20133380.","DOI":"10.1007\/s43032-025-01967-8"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Zhao Y, Zhao X, Jiang T, Xi H, Jiang Y, Feng X. A Retrospective Review on Dysregulated Autophagy in Polycystic Ovary Syndrome: From Pathogenesis to Therapeutic Strategies. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme. 2024; 56: 547\u2013558.","DOI":"10.1055\/a-2280-7130"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Yan X, Ma D, Li R, Xu J, Zou Y, He M. The role of mitochondrial dysfunction in ovarian granulosa cells in polycystic ovary syndrome. Endocrine Connections. 2025; 14: e250186.","DOI":"10.1530\/EC-25-0186"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Ganley I. The Importance of Being Autophagic. The New England Journal of Medicine. 2021; 384: 2449\u20132450.","DOI":"10.1056\/NEJMe2107506"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhang C, Hu J, Wang W, Sun Y, Sun K. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2020; 34: 9563\u20139574.","DOI":"10.1096\/fj.202000605RR"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Zhou J, Peng X, Mei S. Autophagy in Ovarian Follicular Development and Atresia. International Journal of Biological Sciences. 2019; 15: 726\u2013737.","DOI":"10.7150\/ijbs.30369"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kumariya S, Ubba V, Jha RK, Gayen JR. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy. 2021; 17: 2706\u20132733.","DOI":"10.1080\/15548627.2021.1938914"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Gao Y, Zou Y, Wu G, Zheng L. Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Frontiers in Medicine. 2023; 10: 1193749.","DOI":"10.3389\/fmed.2023.1193749"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Liu H, Jin L, Wang X, Shi J, He Y, Sun N, et al. Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities. Redox Biology. 2025; 85: 103776.","DOI":"10.1016\/j.redox.2025.103776"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hu R, Huang Y, Liu Z, Dong H, Ma W, Song K, et al. Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets. Reproductive Biomedicine Online. 2025; 50: 104296.","DOI":"10.1016\/j.rbmo.2024.104296"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Sun YC, Wang YY, Sun XF, Cheng SF, Li L, Zhao Y, et al. The role of autophagy during murine primordial follicle assembly. Aging. 2018; 10: 197\u2013211.","DOI":"10.18632\/aging.101376"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Choi J, Jo M, Lee E, Choi D. AKT is involved in granulosa cell autophagy regulation via mTOR signaling during rat follicular development and atresia. Reproduction (Cambridge, England). 2014; 147: 73\u201380.","DOI":"10.1530\/REP-13-0386"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Song X, Shen Q, Fan L, Yu Q, Jia X, Sun Y, et al. Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome. Oncotarget. 2018; 9: 11905\u201311921.","DOI":"10.18632\/oncotarget.24190"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Wici\u0144ski M, Erdmann J, Nowacka A, Ku\u017ami\u0144ski O, Michalak K, Janowski K, et al. Natural Phytochemicals as SIRT Activators-Focus on Potential Biochemical Mechanisms. Nutrients. 2023; 15: 3578.","DOI":"10.3390\/nu15163578"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Wu M, Zhang J, Gu R, Dai F, Yang D, Zheng Y, et al. The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome. European Journal of Medical Research. 2022; 27: 158.","DOI":"10.1186\/s40001-022-00746-4"},{"key":"ref32","unstructured":"Ma Z, Hu J, Deng Y, Xing G, Wang L. Mechanistic study on the effect of resveratrol on autophagy in ovarian granulosa cells of rats with polycystic ovary syndrome through regulation of the Akt\/mTOR pathway. Journal of Chongqing Medical University. 2021; 46: 388\u2013393. (In Chinese)"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Cant\u00f3 C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009; 458: 1056\u20131060.","DOI":"10.1038\/nature07813"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Di Emidio G, Falone S, Vitti M, D'Alessandro AM, Vento M, Di Pietro C, et al. SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging. Human Reproduction (Oxford, England). 2014; 29: 2006\u20132017.","DOI":"10.1093\/humrep\/deu160"},{"key":"ref35","unstructured":"Deng Y, Ma Z, Hu J, Wen Y, Qu H, Gui W. Mechanistic study of resveratrol inhibiting autophagy in ovarian granulosa cells of rats with polycystic ovary syndrome by regulating the SIRT1\/AMPK pathway. Journal of Chongqing Medical University. 2022; 47: 700\u2013704. (In Chinese)"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Bertoldo A, Pizzol D, Yon DK, Callegari M, Gobbo V, Cuccurese P, et al. Resveratrol and Female Fertility: A Systematic Review. International Journal of Molecular Sciences. 2024; 25: 12792.","DOI":"10.3390\/ijms252312792"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Kurek Eken M, Sahin Ersoy G, Yayla Abide C, Sanverdi \u0130, Devranoglu B, Kutlu T, et al. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology. 2019; 39: 975\u2013980.","DOI":"10.1080\/01443615.2019.1581754"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences. 2019; 236: 116940.","DOI":"10.1016\/j.lfs.2019.116940"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Joshi A. PCOS stratification for precision diagnostics and treatment. Frontiers in Cell and Developmental Biology. 2024; 12: 1358755.","DOI":"10.3389\/fcell.2024.1358755"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Barber TM. Why are women with polycystic ovary syndrome obese? British Medical Bulletin. 2022; 143: 4\u201315.","DOI":"10.1093\/bmb\/ldac007"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Houston EJ, Templeman NM. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. The Journal of Endocrinology. 2025; 265: e240269.","DOI":"10.1530\/JOE-24-0269"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J, et al. Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reproductive Biology and Endocrinology : RB&E. 2024; 22: 159.","DOI":"10.1186\/s12958-024-01337-0"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Zuo T, Zhu M, Xu W. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxidative Medicine and Cellular Longevity. 2016; 2016: 8589318.","DOI":"10.1155\/2016\/8589318"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Sztretye M, Dienes B, G\u00f6nczi M, Czirj\u00e1k T, Csernoch L, Dux L, et al. Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging. Oxidative Medicine and Cellular Longevity. 2019; 2019: 3849692.","DOI":"10.1155\/2019\/3849692"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Wojcik M, Krawczyk M, Zieleniak A, Mac Marcjanek K, Wozniak LA. Chapter 14 - Associations of high blood sugar with oxidative stress and inflammation in patients with type 2 diabetes. In Preuss HG, Bagchi D (eds.) Dietary Sugar, Salt and Fat in Human Health (pp. 305\u2013323). Academic Press: London, United Kingdom. 2020.","DOI":"10.1016\/B978-0-12-816918-6.00014-7"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Malin SK, Kirwan JP, Sia CL, Gonz\u00e1lez F. Pancreatic \u03b2-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-\u03baB activation and systemic inflammation. American Journal of Physiology. Endocrinology and Metabolism. 2015; 308: E770\u2013E777.","DOI":"10.1152\/ajpendo.00510.2014"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Tan Y, Miao L, Xiao J, Cheang WS. 3,3',4,5'-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS\/PI3K\/Akt Pathway and Inhibiting Oxidative Stress. Current Issues in Molecular Biology. 2022; 44: 2175\u20132185.","DOI":"10.3390\/cimb44050147"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Shu L, Zhao H, Huang W, Hou G, Song G, Ma H. Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt Pathway to Improve Insulin Resistance Induced by a High-Fat Diet in Mice. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 2020; 13: 391\u2013403.","DOI":"10.2147\/DMSO.S240956"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Brasny\u00f3 P, Moln\u00e1r GA, Moh\u00e1s M, Mark\u00f3 L, Laczy B, Cseh J, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. The British Journal of Nutrition. 2011; 106: 383\u2013389.","DOI":"10.1017\/S0007114511000316"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Sun X, Cao Z, Ma Y, Shao Y, Zhang J, Yuan G, et al. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K\/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes. Food & Function. 2021; 12: 1207\u20131218.","DOI":"10.1039\/d0fo02387f"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Ergenoglu M, Yildirim N, Yildirim AGS, Yeniel O, Erbas O, Yavasoglu A, et al. Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome. Reproductive Sciences (Thousand Oaks, Calif.). 2015; 22: 942\u2013947.","DOI":"10.1177\/1933719115570900"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Ghowsi M, Khazali H, Sisakhtnezhad S. Evaluation of TNF-\u03b1 and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iranian Journal of Basic Medical Sciences. 2018; 21: 165\u2013174.","DOI":"10.22038\/IJBMS.2017.24801.6167"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Brenjian S, Moini A, Yamini N, Kashani L, Faridmojtahedi M, Bahramrezaie M, et al. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 2020; 83: e13186.","DOI":"10.1111\/aji.13186"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic Ovary Syndrome and Oxidative Stress-From Bench to Bedside. International Journal of Molecular Sciences. 2023; 24: 14126.","DOI":"10.3390\/ijms241814126"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Jiang X, Pang Y, Zhao S, Hao H, Zhao X, Du W, et al. Thioredoxin-interacting protein regulates glucose metabolism and improves the intracellular redox state in bovine oocytes during in vitro maturation. American Journal of Physiology. Endocrinology and Metabolism. 2020; 318: E405\u2013E416.","DOI":"10.1152\/ajpendo.00057.2019"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Zhang S, Tu H, Yao J, Le J, Jiang Z, Tang Q, et al. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway. Reproductive Biology and Endocrinology : RB&E. 2020; 18: 58.","DOI":"10.1186\/s12958-020-00613-z"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Zhao YK, Gao YN, Wang LC, Wang J, Wang GJ, Wu HL. Correlation between abnormal energy metabolism of ovarian granulosa cells and in vitro fertilization-embryo transfer outcomes in patients with polycystic ovary syndrome and obesity. Journal of Ovarian Research. 2023; 16: 145.","DOI":"10.1186\/s13048-023-01204-3"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Lin Y, Fridstr\u00f6m M, Hillensj\u00f6 T. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries. Human Reproduction (Oxford, England). 1997; 12: 2469\u20132472.","DOI":"10.1093\/humrep\/12.11.2469"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Chow HM, Shi M, Cheng A, Gao Y, Chen G, Song X, et al. Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence. Nature Neuroscience. 2019; 22: 1806\u20131819.","DOI":"10.1038\/s41593-019-0505-1"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Liang A, Huang L, Liu H, He W, Lei X, Li M, et al. Resveratrol Improves Follicular Development of PCOS Rats by Regulating the Glycolytic Pathway. Molecular Nutrition & Food Research. 2021; 65: e2100457.","DOI":"10.1002\/mnfr.202100457"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Liang A, Zhang W, Wang Q, Huang L, Zhang J, Ma D, et al. Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells. Frontiers in Nutrition. 2023; 9: 1019562.","DOI":"10.3389\/fnut.2022.1019562"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Zhou F, Zhang L, Zhu K, Bai M, Zhang Y, Zhu Q, et al. SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux. Theranostics. 2021; 11: 4825\u20134838.","DOI":"10.7150\/thno.55330"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Watanabe H, Inaba Y, Kimura K, Matsumoto M, Kaneko S, Kasuga M, et al. Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein. Nature Communications. 2018; 9: 30.","DOI":"10.1038\/s41467-017-02537-6"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Cao Z, Zhou Q, An J, Guo X, Jia X, Qiu Y. Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome. Drug Design, Development and Therapy. 2025; 19: 5255\u20135270.","DOI":"10.2147\/DDDT.S525651"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Psilopatis I, Vrettou K, Nousiopoulou E, Palamaris K, Theocharis S. The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome. Journal of Clinical Medicine. 2023; 12: 2912.","DOI":"10.3390\/jcm12082912"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Han L, Shen WJ, Bittner S, Kraemer FB, Azhar S. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3. Future Cardiology. 2017; 13: 279\u2013296.","DOI":"10.2217\/fca-2017-0019"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Wagner KD, Wagner N. Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacology & Therapeutics. 2010; 125: 423\u2013435.","DOI":"10.1016\/j.pharmthera.2009.12.001"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism: Clinical and Experimental. 2021; 114: 154338.","DOI":"10.1016\/j.metabol.2020.154338"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Milton-Lask\u00edbar I, G\u00f3mez-Zorita S, Arias N, Romo-Miguel N, Gonz\u00e1lez M, Fern\u00e1ndez-Quintela A, et al. Effects of resveratrol and its derivative pterostilbene on brown adipose tissue thermogenic activation and on white adipose tissue browning process. Journal of Physiology and Biochemistry. 2020; 76: 269\u2013278.","DOI":"10.1007\/s13105-020-00735-3"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Shamardl HAMA, Ibrahim NA, Merzeban DH, Elamir AM, Golam RM, Elsayed AM. Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 \/ adipokines \/ PPAR\u03b3 and IGF-1. Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2023; 31: 13\u201327.","DOI":"10.1007\/s40199-023-00458-y"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Zhang N, Zhuang L, Gai S, Shan Y, Wang S, Li F, et al. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 2021; 37: 337\u2013341.","DOI":"10.1080\/09513590.2020.1812569"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Wang P, Li D, Ke W, Liang D, Hu X, Chen F. Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. International Journal of Obesity (2005). 2020; 44: 213\u2013225.","DOI":"10.1038\/s41366-019-0332-1"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews. 2016; 37: 467\u2013520.","DOI":"10.1210\/er.2015-1104"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, et al. Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis. Journal of Ovarian Research. 2014; 7: 21.","DOI":"10.1186\/1757-2215-7-21"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Banaszewska B, Wroty\u0144ska-Barczy\u0144ska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial. The Journal of Clinical Endocrinology and Metabolism. 2016; 101: 4322\u20134328.","DOI":"10.1210\/jc.2016-1858"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Hassan S, Shah M, Malik MO, Ehtesham E, Habib SH, Rauf B. Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial. Endocrine. 2023; 79: 208\u2013220.","DOI":"10.1007\/s12020-022-03198-2"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Mansour A, Samadi M, Sanginabadi M, Gerami H, Karimi S, Hosseini S, et al. Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clinical Nutrition (Edinburgh, Scotland). 2021; 40: 4106\u20134112.","DOI":"10.1016\/j.clnu.2021.02.004"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2004; 18: 671\u2013683.","DOI":"10.1016\/j.bpobgyn.2004.05.001"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Thomas JL, Eichmann A. The power of VEGF (vascular endothelial growth factor) family molecules. Cellular and Molecular Life Sciences : CMLS. 2013; 70: 1673\u20131674.","DOI":"10.1007\/s00018-013-1276-6"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Dambala K, Vavilis D, Bili E, Goulis DG, Tarlatzis BC. Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 2017; 33: 529\u2013533.","DOI":"10.1080\/09513590.2017.1296425"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Dambala K, Paschou SA, Michopoulos A, Siasos G, Goulis DG, Vavilis D, et al. Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome. Angiology. 2019; 70: 797\u2013801.","DOI":"10.1177\/0003319719840091"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Di Pietro M, Pascuali N, Parborell F, Abramovich D. Ovarian angiogenesis in polycystic ovary syndrome. Reproduction (Cambridge, England). 2018; 155: R199\u2013R209.","DOI":"10.1530\/REP-17-0597"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Tal R, Seifer DB, Arici A. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. Seminars in Reproductive Medicine. 2015; 33: 195\u2013207.","DOI":"10.1055\/s-0035-1552582"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Ochiai A, Kuroda K, Ikemoto Y, Ozaki R, Nakagawa K, Nojiri S, et al. Influence of resveratrol supplementation on IVF-embryo transfer cycle outcomes. Reproductive Biomedicine Online. 2019; 39: 205\u2013210.","DOI":"10.1016\/j.rbmo.2019.03.205"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Hashemi Taheri AP, Moradi B, Radmard AR, Sanginabadi M, Qorbani M, Mohajeri-Tehrani MR, et al. Effect of resveratrol administration on ovarian morphology, determined by transvaginal ultrasound for the women with polycystic ovary syndrome (PCOS). The British Journal of Nutrition. 2022; 128: 211\u2013216.","DOI":"10.1017\/S0007114521003330"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Malvasi A, Tinelli A, Lupica G, Vimercati A, Spyropoulou K, Dellino M, et al. Effects of a combination of resveratrol and alpha-lipoic acid on body weight and adipose composition in women with PCOS: a preliminary pilot study. European Review for Medical and Pharmacological Sciences. 2022; 26: 6578\u20136582.","DOI":"10.26355\/eurrev_202209_29757"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Ardehjani NA, Agha-Hosseini M, Nashtaei MS, Khodarahmian M, Shabani M, Jabarpour M, et al. Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial. Journal of Ovarian Research. 2024; 17: 143.","DOI":"10.1186\/s13048-024-01470-9"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Ochiai A, Kuroda K. Preconception resveratrol intake against infertility: Friend or foe? Reproductive Medicine and Biology. 2020; 19: 107\u2013113.","DOI":"10.1002\/rmb2.12303"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Conforti A, Iorio GG, Di Girolamo R, Rovetto MY, Picarelli S, Cariati F, et al. The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial. Journal of Ovarian Research. 2024; 17: 81.","DOI":"10.1186\/s13048-024-01391-7"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Giuliani C, Iezzi M, Ciolli L, Hysi A, Bucci I, Di Santo S, et al. Resveratrol has anti-thyroid effects both in vitro and in vivo. Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2017; 107: 237\u2013247.","DOI":"10.1016\/j.fct.2017.06.044"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Ramli I, Posadino AM, Giordo R, Fenu G, Fardoun M, Iratni R, et al. Effect of Resveratrol on Pregnancy, Prenatal Complications and Pregnancy-Associated Structure Alterations. Antioxidants (Basel, Switzerland). 2023; 12: 341.","DOI":"10.3390\/antiox12020341"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Stener-Victorin E. Update on Animal Models of Polycystic Ovary Syndrome. Endocrinology. 2022; 163: bqac164.","DOI":"10.1210\/endocr\/bqac164"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Bevilacqua A, Giuliani C, Emidio GD, Myers SH, Unfer V, Tatone C. Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome. Advanced Biology. 2025; 9: e2400713.","DOI":"10.1002\/adbi.202400713"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Poojary PS, Nayak G, Panchanan G, Rao A, Kundapur SD, Kalthur SG, et al. Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. Endocrinology. 2022; 163: bqac097.","DOI":"10.1210\/endocr\/bqac097"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Frontiers in Endocrinology. 2023; 14: 1191759.","DOI":"10.3389\/fendo.2023.1191759"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL50398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:18:30Z","timestamp":1785413910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL50398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02106-4"],"URL":"https:\/\/doi.org\/10.31083\/fbl50398","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"50398"}}